Our therapeutic areas of expertise

At NWEH, we focus on areas where clinical research can make the biggest difference to patients and health systems. With decades of experience, our team has supported studies across diverse conditions, building the evidence needed to improve treatment, accelerate innovation and expand access to care.

Our research is guided by leading clinicians, researchers and safety experts who bring deep knowledge and real-world insight to every study. With leadership from figures such as Professor Martin Gibson (Founder and CMO), Professor Nawar Barkley (Chair of our Medical Advisory Group) and Claire Williams (Head of Pharmacovigilance), Dr Sylwia Migas (Head of Data Science and Analytics) and Jo Verity (Head of Clinical Operations) we ensure our research is grounded in clinical excellence and delivers meaningful impact for patients, sponsors and healthcare systems.

Explore our focus therapy areas to see why they matter and how NWEH is helping to shape the future of research.

 

Endocrinology

Endocrine and metabolic disorders like diabetes, obesity, and thyroid disease are among the fastest-growing global health challenges. Guided by Professor Martin Gibson, NWEH delivers research expertise from feasibility to large-scale trials, generating real-world evidence to advance metabolic health. Why NWEH? We reduce the burden on clinicians, helping to accelerate recruitment and provide consistent communication across GP networks.

Women's health

Women’s health has long been underrepresented in research. NWEH is committed to closing this gap by enabling inclusive studies on conditions unique to or more common in women, guided by Claire Williams’ expertise in safety, monitoring, and real-world evidence. Why NWEH? One of our core priorities are ensuring diversity and inclusivity in clinical trials, including women and hard-to-reach populations.

Respiratory

NWEH has deep expertise in respiratory research, leading studies like the groundbreaking Salford Lung Study that redefined real-world trial design, guided by respiratory expert Professor Nawar Barkley. Why NWEH? We pioneered real-world research with the Salford Lung Study and continue to deliver pragmatic trials with proven impact at scale.

Infectious diseases

From pandemics to seasonal infections, infectious diseases remain a major research priority. NWEH played a key role in COVID-19 trials and continues to support vaccine, treatment, and antimicrobial resistance studies, quickly mobilising to reach broad patient populations. Why NWEH? Our FARSITE technology provides real-time feasibility to tackle the time constraints associated with efficacy testing for new antivirals.

Autoimmune diseases

Autoimmune diseases are complex and often underdiagnosed, affecting millions worldwide. NWEH supports studies that ensure diverse recruitment, capture real-world experiences, and help develop therapies that deliver meaningful benefits for patients. Why NWEH? We have developed pioneering clinical trial technology which facilitates patient recruitment and streamlines data analysis.

Gastrointestinal

Gastrointestinal conditions like IBD, IBS, and liver disease are increasing and greatly affect patients’ lives. NWEH delivers inclusive studies that capture real-world experience and generate evidence to improve treatments and care pathways. Why NWEH? We have both the technology and the footprint in Greater Manchester to support the priorities of researchers, at speed.

 

Driving Better Research, Together

Our focus areas highlight where NWEH has delivered the greatest impact – from obesity and women’s health to respiratory and beyond. Our expertise is not limited to these fields. With proven capability in pragmatic trial design, patient engagement and real-world data integration, we partner across therapy areas to generate the evidence that drives innovation and improves outcomes.

Partner with NWEH to turn real-world data into real-world impact.

Get in touch

Discover more. Deliver better.

Talk to us about your clinical trials

Get in touch